In vitro studies, immunohistochemistry in tumor specimens, and correlation analyses in tissue specimens confirmed that genistein increased CREB1, pCREB1(S133) and EMP2 protein levels, and that the EMP2 was transactivated by pCREB1(S133). The gene discussed is CREB1; the disease is neoplasm.